Accendra Health provides update on CEO transition, credit facility
By HME News Staff
Updated 10:11 AM CDT, Mon August 17, 2026
RICHMOND, Va. – Accendra Health says it plans to name a successor to CEO Edward Pesicka by mid-September, positioning the company for a timely leadership transition ahead of his retirement at the end of the year. “The company’s board of directors has maintained a comprehensive, long-standing CEO succession planning process supported by leading executive search and advisory firms,” it stated. “Following Mr. Pesicka’s formal announcement of his intention to retire by the end of 2026, the board promptly advanced the next phase of its succession process and has been actively evaluating candidates. The board has identified a strong pipeline of potential candidates with the experience and capabilities needed to lead the company into its next phase of growth.” Accendra Health has also announced that it will not put in place an at-the-market issuance program. It has undrawn on its $300 million revolving credit facility at the end of the second quarter and does not expect to rely on that facility other than to address occasional working capital fluctuations. Additionally, Accendra Health provided an update on the sale of two non-core assets: The first closed in the third quarter and the second is expected to close before the end of the year. Together, these sales represent a cash injection of approximately $45 million in the third and fourth quarters of the year, the company says.
Comments